MMA Embolization for Refractory Chronic Migraine
Clinical trial NCT06735833 · RECRUITING
Trial details
- NCT number
- NCT06735833
- Sponsor
- Cerenovus, Part of DePuy Synthes Products, Inc.
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-23
- Primary completion
- 2026-12-25
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.